Hybrid cells are used to produce antibodies by the Antibody Hybridoma Core at Mayo Clinic in Minnesota.


The Antibody Hybridoma Core at Mayo Clinic's campus in Rochester, Minnesota, provides a full range of services and guidance for clients seeking custom hybridoma monoclonal antibody production. Monoclonal antibodies can be used for research and development of clinical diagnostic assays and therapeutics.

All Antibody Hybridoma Core services are available a la carte, which allows the core to take a highly customized approach to each investigator's project. Some researchers have the core handle their projects from start to finish, while other investigators perform some aspects — such as screening assays — in their own laboratories, which helps minimize costs.

Directed by Kay L. Medina, Ph.D., the Antibody Hybridoma Core provides services to all Mayo Clinic faculty and staff engaged in research. Additionally, services are offered to non-Mayo investigators and research collaborators. For more information, please contact the core.